Literature DB >> 32125461

Flos lonicerae flavonoids attenuate experimental ulcerative colitis in rats via suppression of NF-κB signaling pathway.

Daming Liu1, Xiao Yu2, Huiyi Sun3, Wen Zhang3, Guo Liu4, Li Zhu5.   

Abstract

This study sought to isolate active Flos lonicerae flavonoids and evaluate their anti-oxidative and anti-inflammatory effects as well as investigate the molecular mechanistic action of these flavonoids in the rat model of ulcerative colitis (UC). Total flavonoids and three flavonoids (hyperoside, lonicerin, and luteolin) were isolated from honeysuckle and purified via column purification. Rat model of UC was established via 2,4,6-trinitrobenzene sulfonic acid (TNBS) intoxication. The anti-oxidative and anti-inflammatory effects of the three flavonoids against TNBS-induced UC were evaluated by measuring appropriate biomarkers via assay kit. The effects of hyperoside, lonicerin, and luteolin on the regulation of nuclear factor-kappa B (NF-κB) pathway were investigated using Western blot (WB) and real-time polymerase chain reaction (RT-PCR) while their protective effects on UC were also elucidated. Pretreatment with flavonoids (hyperoside, lonicerin, and luteolin at 25-100 mg/kg) and sulfasalazine (SSZ, positive control at 100 mg/kg) substantially attenuated TBNS-induced UC. Also, the flavonoids significantly reduced the levels of respective serum oxidative and proinflammatory markers such as superoxide dismutase (SOD), myeloperoxidase (MPO), malondialdehyde (MDA), prostaglandins E2 (PGE2), tumor necrosis factor-alpha (TNF-α), interleukin-beta (IL-β), and C-reactive protein (CRP). In addition, the flavonoids remarkably inhibited the expression of NF-κB signaling pathway. F. lonicerae flavonoids (hyperoside, lonicerin, and luteolin) demonstrated potent anti-UC activities in TBNS-induced UC rat model via anti-oxidative and anti-inflammatory effects through the inhibition of NF-κB signaling pathway.

Entities:  

Keywords:  Flavonoids; Hyperoside; Inflammation; Lonicerin and luteolin; NF-κB signaling pathway; Ulcerative colitis

Year:  2020        PMID: 32125461     DOI: 10.1007/s00210-020-01814-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

Review 1.  Pharmacological Effects of Polyphenol Phytochemicals on the Intestinal Inflammation via Targeting TLR4/NF-κB Signaling Pathway.

Authors:  Caiyun Yu; Dong Wang; Zaibin Yang; Tian Wang
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 2.  Hyperoside: A Review of Its Structure, Synthesis, Pharmacology, Pharmacokinetics and Toxicity.

Authors:  Sijin Xu; Shuaipeng Chen; Wenxin Xia; Hong Sui; Xueyan Fu
Journal:  Molecules       Date:  2022-05-07       Impact factor: 4.927

3.  Network Pharmacology-Based Identification of Potential Targets of Lonicerae japonicae Flos Acting on Anti-Inflammatory Effects.

Authors:  Xiaoying Guo; Xiao Yu; Bingqing Zheng; Longfei Zhang; Fang Zhang; Yongqing Zhang; Jia Li; Gaobin Pu; Lijun Zhang; Haifeng Wu
Journal:  Biomed Res Int       Date:  2021-09-20       Impact factor: 3.411

4.  Characterization of Constituents with Potential Anti-Inflammatory Activity in Chinese Lonicera Species by UHPLC-HRMS Based Metabolite Profiling.

Authors:  Eva-Maria Pferschy-Wenzig; Sabine Ortmann; Atanas G Atanasov; Klara Hellauer; Jürgen Hartler; Olaf Kunert; Markus Gold-Binder; Angela Ladurner; Elke H Heiß; Simone Latkolik; Yi-Min Zhao; Pia Raab; Marlene Monschein; Nina Trummer; Bola Samuel; Sara Crockett; Jian-Hua Miao; Gerhard G Thallinger; Valery Bochkov; Verena M Dirsch; Rudolf Bauer
Journal:  Metabolites       Date:  2022-03-25

5.  Integrative Metabolome and Transcriptome Analysis Reveals the Regulatory Network of Flavonoid Biosynthesis in Response to MeJA in Camelliavietnamensis Huang.

Authors:  Heqin Yan; Wei Zheng; Yong Wang; Yougen Wu; Jing Yu; Pengguo Xia
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

6.  Huangkui lianchang decoction attenuates experimental colitis by inhibiting the NF-κB pathway and autophagy.

Authors:  Xudong Cheng; Jun Du; Qing Zhou; Bensheng Wu; Haodong Wang; Zhizhong Xu; Shuguang Zhen; Jieyu Jiang; Xiaopeng Wang; Zongqi He
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

Review 7.  Bioactive natural compounds against human coronaviruses: a review and perspective.

Authors:  Yanfang Xian; Juan Zhang; Zhaoxiang Bian; Hua Zhou; Zhenbiao Zhang; Zhixiu Lin; Hongxi Xu
Journal:  Acta Pharm Sin B       Date:  2020-06-08       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.